Pharmacists in Bay Pines, Florida
164 Pharmacists found in Bay Pines
Dr. John Mark Hoeldtke, PHARMD
Pharmacist - Pharmacotherapy
10,000 Bay Pines Blvd, Bay Pines, FL 33744
727-398-6661 727-398-9506
Mr. John H Caulder, RPH
Pharmacist
Dept Of Veterans Affairs, 10,000 Bay Pines Blvd, Bay Pines, FL 33744
727-398-6661
Dr. John Mark Trotter, PHARM.D.
Pharmacist - Pharmacotherapy
10000 Bay Pines Blvd, Bay Pines, FL 33708
727-398-6661 727-398-9506
Dr. John Charles Leonard Jr., PHARMD
Pharmacist
10000 Bay Pines Blvd, Bay Pines, FL 33744
727-398-6661
Dr. John Thomas Winiecki, PHARM.D.
Pharmacist
10000 Bay Pines Blvd, Vamc Bay Pines, Bay Pines, FL 33744
727-398-6661 727-398-9506
Dr. Joseph Hong, PHARM.D.
Pharmacist
10000 Bay Pines Blvd, Mail Code 119, Bay Pines, FL 33744
727-398-6661 727-398-9506
Dr. Joseph Daniel Justino, PHARM D, BCPP
Pharmacist - Psychiatric
10000 Bay Pines Blvd, Bay Pines, FL 33744
727-398-6661
Dr. Joshua Thomas Qualls, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
10000 Bay Pines Blvd, Bay Pines, FL 33744
239-287-9408
Dr. Joshua C. Long, PHARM.D.
Pharmacist
10000 Bay Pines Blvd Unit 119, Bay Pines, FL 33744
727-398-6661
Ms. Judy W Palmer, RPH
Pharmacist
10000 Bay Pines Blvd, Bay Pines, FL 33744
727-398-6661 727-398-9506
Dr. Katherine Antonette Callahan, PHARMD
Pharmacist
10000 Bay Pines Blvd, Bay Pines, FL 33744
727-398-6661
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.